As expected, a higher frequency of intratumoral CD8+ T cell infiltration and high tumor MHC-I expression was detected in responders compared with nonresponders (Figure 6, A and D, and Supplemental Figure 13A). This evidence concerns the gene CD8A and neoplasm.